ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
23.109,79
1,11%
S&P 500
5.776,65
0,16%
Dow Jones
42.587,50
0,01%
Euro vs US Dollar
1,07943
0,07%
Bitcoin
87.282,04
-0,21%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Alzamend Neuro Inc (ALZN) Börsenkurse

Alzamend Neuro Inc

Alzamend Neuro Inc (ALZN)

NASDAQ
1,01
-0,01
(-0,98%)
Geschlossen 26 März 9:00PM
Verzögert um 15 Minuten
0,9913
-0,0187
(-1,85%)
Nach Börsenschluss: 12:46AM
Verzögert um 15 Minuten
Fortg. Diagramm

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
0,9913
Gebot
0,99
Fragen
1,10
Volumen
342.549
0,9529 Tagesbereich 1,13
0,6427 52-Wochen-Bereich 15,06
Marktkapitalisierung
6,54M
Handelsende
1,02
Handelsbeginn
1,13
Letzte Trade
100
@
0.9913
(formt)
Letzter Handelszeitpunkt
Finanzvolumen
US$ 348.796
VWAP
1,0182
Durchschnittliches Volumen (3 Mio.)
401.993
Ausgegebene Aktien
6.597.507
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,66
Gewinn pro Aktie (EPS)
-1,51
Erlöse
-
Nettogewinn
-9,95M

Über Alzamend Neuro Inc

Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipe... Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.alzamend.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Alzamend Neuro Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALZN. The last closing price for Alzamend Neuro was US$1,02. Over the last year, Alzamend Neuro shares have traded in a share price range of US$ 0,6427 to US$ 15,06.

Alzamend Neuro currently has 6.597.507 shares in issue. The market capitalisation of Alzamend Neuro is US$6,73 million. Alzamend Neuro has a price to earnings ratio (PE ratio) of -0.66.

ALZN Neueste Nachrichten

Weitere Nachrichten

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
24 März 2025
ALZN (-0,98%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
13 März 2025
ALZN (-0,98%)

Form S-3 - Registration statement under Securities Act of 1933
Edgar (US Regulatory)
13 März 2025
ALZN (-0,98%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
10 März 2025
ALZN (-0,98%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.091310.14444444440.91.050.8252633790.96633019CS
40.121313.94252873560.871.050.64271985070.86217921CS
12-0.2287-18.74590163931.221.30.64274019930.99971415CS
26-0.5887-37.25949367091.581.90.64272937071.18917606CS
52-9.6087-90.648113207510.615.060.64275874054.30539991CS
156-185.0087-99.46704301081862250.642741978169.55797748CS
260-4349.0087-99.977211494343505032.50.64271083235361.04737772CS

ALZN - Frequently Asked Questions (FAQ)

What is the current Alzamend Neuro share price?
The current share price of Alzamend Neuro is US$ 0,9913
How many Alzamend Neuro shares are in issue?
Alzamend Neuro has 6.597.507 shares in issue
What is the market cap of Alzamend Neuro?
The market capitalisation of Alzamend Neuro is USD 6,73M
What is the 1 year trading range for Alzamend Neuro share price?
Alzamend Neuro has traded in the range of US$ 0,6427 to US$ 15,06 during the past year
What is the PE ratio of Alzamend Neuro?
The price to earnings ratio of Alzamend Neuro is -0,66
What is the reporting currency for Alzamend Neuro?
Alzamend Neuro reports financial results in USD
What is the latest annual profit for Alzamend Neuro?
The latest annual profit of Alzamend Neuro is USD -9,95M
What is the registered address of Alzamend Neuro?
The registered address for Alzamend Neuro is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Alzamend Neuro website address?
The website address for Alzamend Neuro is www.alzamend.com
Which industry sector does Alzamend Neuro operate in?
Alzamend Neuro operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
TNONTenon Medical Inc
US$ 3,82
(290,55%)
291,65M
GDHGGolden Heaven Group Holdings Ltd
US$ 3,7606
(91,87%)
33,35M
DATSDatChat Inc
US$ 3,78
(75,00%)
143,62M
RAYRaytech Holding Ltd
US$ 1,98
(52,31%)
15,19M
POAIPredictive Oncology Inc
US$ 1,6806
(50,73%)
152,85M
MURAMural Oncology PLC
US$ 1,48
(-61,36%)
4,04M
BACKIMAC Holdings Inc
US$ 0,19
(-55,02%)
6,29M
CNSPCNS Pharmaceuticals Inc
US$ 1,61
(-52,37%)
2,4M
WLGSWang and Lee Group Inc
US$ 0,433
(-42,34%)
14,2M
SGLYSingularity Future Technology Ltd
US$ 0,885786
(-40,55%)
1,33M
MULNMullen Automotive Inc
US$ 0,2377
(-7,08%)
418,4M
TNONTenon Medical Inc
US$ 3,82
(290,55%)
291,65M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 11,8507
(6,19%)
242,56M
NVDANVIDIA Corporation
US$ 120,69
(-0,59%)
167,46M
BONBon Natural Life Ltd
US$ 0,1615
(8,32%)
153,12M

ALZN Finanzen

Finanzen

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
ALZN
Alzamend Neuro
COIN
XASUSD
Asch
USOTC
IBIDF
Ibiden (PK)
Delayed Upgrade Clock
ADVFN Logo
Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten